Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X0FW
|
|||
| Former ID |
DIB005503
|
|||
| Drug Name |
B1-655075
|
|||
| Indication | Coagulation defect [ICD-11: 3B10.0] | Phase 1 | [1] | |
| Company |
Boehringer 1ngelheim pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Boehringer Ingelheim Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.